In the framework of circular bio-economy, waste loquat seeds were utilized for the production of two added-value products. The seeds were hydrothermally carbonized at a temperature range of 150-250 °C and time range 2-6 h and the resultant hydrochars and aqueous phases were characterized using various methods. The optimum higher heating value of 30.64 MJ kg, ash content of 1.99 wt % and alkali index of 0.05 were achieved for the hydrochar prepared at 250 °C and 6 h, establishing its suitability for energy-related applications. The aqueous phase obtained at 250 °C and 6 h achieved 90% scavenging of the 2,2-diphenyl-1-picryl-hydrazyl-hydrate (DPPH) radical and had a IC value of 43.71 μg mL. Principal component analysis showed that the production of phenols, ketones, alkenes and organic acids was favored at >200 °C, whereas furans and aldehydes were primarily formed at 150 °C. Conclusively, both added-value products were obtained at the same optimum hydrothermal carbonization conditions of 250 °C and 6 h treatment time. In a bio-refinery context, this has the practical implication that both bio-products be obtained simultaneously, without the need to switch between different temperatures and residence times.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jenvman.2023.118612DOI Listing

Publication Analysis

Top Keywords

added-value products
12
250 °c 6 h
12
loquat seeds
8
hydrothermal carbonization
8
hydrochars aqueous
8
aqueous phases
8
valorization loquat
4
seeds hydrothermal
4
carbonization production
4
production hydrochars
4

Similar Publications

Metagenomics-based tracing of genetically modified microorganism contaminations in commercial fermentation products.

Food Chem (Oxf)

June 2025

Sciensano, Transversal activities in Applied Genomics (TAG), J. Wytsmanstraat 14, 1050 Brussels, Belgium.

Genetically modified microorganisms (GMM) are frequently employed for the production of microbial fermentation products such as food enzymes. Although presence of the GMM or its recombinant DNA in the final product is not authorized, contaminations occur frequently. Insight into the contamination source of a GMM is of crucial importance to allow the competent authorities to take appropriate action.

View Article and Find Full Text PDF

As part of an innovative project initiated by the Quality and Risk Management Department and the Institut de Formation en Soins Infirmiers (Ifsi) at the Laon hospital in the Aisne region of France, a semester 5 nursing student was given the opportunity to put her initial training in quality, risk management and assessment of professional practices to good use during a five-week work placement. Her feedback, like that of the quality department and Ifsi, was positive.

View Article and Find Full Text PDF

Hydrolyzing collagen by extracellular protease Hap of Aeromonas salmonicida: Turning chicken by-products into bioactive resources.

Food Chem

January 2025

State Key Laboratory of Meat Quality Control and Cultured Meat Development, College of Food Science and Technology, Nanjing Agricultural University, Nanjing 210095, PR China. Electronic address:

Collagen-rich meat processing by-products have potential utilization value. Extracellular protease Hap from meat-borne Aeromonas salmonicida has been identified as an ideal protease for hydrolyzing collagen. Here, to explore the possible application of Hap for giving chicken by-products a high added value, the hydrolysis ability and mechanism were investigated.

View Article and Find Full Text PDF

Acceptance of Evidence Transfer Within German Early Benefit Assessment of New Drugs for Pediatric and Adolescents Target Populations.

Pharmacoeconomics

January 2025

Institute for Health Services Research and Health Economics, Centre for Health and Society, Medical Faculty, Heinrich Heine University, Building: 12.49, Moorenstr. 5, 40225, Düsseldorf, Germany.

Background And Objective: In Germany, all new drugs undergo an early benefit assessment (EBA) by the decision-making body (G-BA). Due to limited access to clinical data in pediatric healthcare since 2017, evidence transfer has allowed for data from adult studies to be used in the EBA of pediatric drugs. This study examines the acceptance of evidence transfer, aiming to understand its correlation with granted added benefit.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!